Tumour-infiltrating lymphocytes and melanoma treatment response
Author Information
Author(s): A Hakansson, B Gustafsson, L Krysander, L Hakansson
Primary Institution: University Hospital, Linkoping, Sweden
Hypothesis
Does the presence of tumour-infiltrating lymphocytes correlate with the therapeutic effect of interferon alpha in melanoma patients?
Conclusion
The presence of CD4+ lymphocytes in tumours is associated with a better response to interferon alpha treatment in melanoma patients.
Supporting Evidence
- Ten out of 11 patients with high CD4+ lymphocyte counts achieved tumor regression.
- Among patients with low CD4+ lymphocyte counts, nine out of ten had progressive disease.
- Statistically significant correlation found between CD4+ lymphocyte presence and treatment response.
Takeaway
If there are more CD4+ immune cells in a melanoma tumor, the treatment with interferon alpha is more likely to work.
Methodology
The study analyzed fine needle aspirates from melanoma patients to assess the correlation between CD4+ lymphocyte presence and treatment response to interferon alpha.
Limitations
The study did not include patients with brain metastases and had a short treatment duration for some patients.
Participant Demographics
41 patients (23 males, 18 females) with a median age of 60 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website